Free Trial

SBC Medical Group (NASDAQ:SBC) Shares Up 16.2% - Time to Buy?

SBC Medical Group logo with Medical background

Key Points

  • SBC Medical Group's stock rose by 16.2% on Monday, trading at a high of $4.86 compared to its previous close of $4.15.
  • Analysts at Wall Street Zen have downgraded SBC Medical Group shares from a "buy" rating to a "hold" rating.
  • The company reported $0.02 earnings per share for the last quarter, falling short of expectations by $0.12, and had a revenue of $43.36 million against the forecast of $44.71 million.
  • MarketBeat previews the top five stocks to own by October 1st.

SBC Medical Group Holdings Incorporated (NASDAQ:SBC - Get Free Report)'s stock price was up 16.2% during trading on Monday . The company traded as high as $4.86 and last traded at $4.82. Approximately 75,211 shares were traded during mid-day trading, an increase of 15% from the average daily volume of 65,225 shares. The stock had previously closed at $4.15.

Analyst Ratings Changes

Separately, Wall Street Zen lowered shares of SBC Medical Group from a "buy" rating to a "hold" rating in a research report on Friday.

View Our Latest Research Report on SBC Medical Group

SBC Medical Group Stock Up 20.2%

The company has a debt-to-equity ratio of 0.03, a quick ratio of 3.95 and a current ratio of 3.98. The stock has a market cap of $518.36 million, a price-to-earnings ratio of 15.59 and a beta of 1.27. The firm's 50-day simple moving average is $4.52 and its two-hundred day simple moving average is $4.13.

SBC Medical Group (NASDAQ:SBC - Get Free Report) last posted its quarterly earnings data on Wednesday, August 13th. The company reported $0.02 earnings per share for the quarter, missing the consensus estimate of $0.14 by ($0.12). SBC Medical Group had a net margin of 17.71% and a return on equity of 20.76%. The company had revenue of $43.36 million during the quarter, compared to analyst estimates of $44.71 million. On average, sell-side analysts expect that SBC Medical Group Holdings Incorporated will post 5.02 EPS for the current fiscal year.

Institutional Investors Weigh In On SBC Medical Group

Several institutional investors have recently modified their holdings of the business. Geode Capital Management LLC acquired a new stake in shares of SBC Medical Group during the 2nd quarter worth approximately $455,000. SBI Securities Co. Ltd. boosted its stake in SBC Medical Group by 227.3% during the 2nd quarter. SBI Securities Co. Ltd. now owns 54,177 shares of the company's stock worth $251,000 after acquiring an additional 37,623 shares during the last quarter. New York State Common Retirement Fund bought a new position in SBC Medical Group during the 2nd quarter worth approximately $104,000. Finally, XTX Topco Ltd bought a new position in SBC Medical Group during the 2nd quarter worth approximately $64,000. Institutional investors and hedge funds own 60.82% of the company's stock.

SBC Medical Group Company Profile

(Get Free Report)

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in SBC Medical Group Right Now?

Before you consider SBC Medical Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SBC Medical Group wasn't on the list.

While SBC Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.